The anticholinergic drugs, atropine and hyoscine are used widely as premedicants before general anaesthesia. A recent postal survey noted that, of anaesthetists in the United Kingdom and Ireland who replied, over 62% used anticholinergic drugs routinely for premedication, and that atropine and hyoscine were the most commonly used drugs (Mirakhur et al., 1978) . The administration of these drugs before operation grew from the recognition of their antisialagogue and antivagal actions which counteracted the effects of the early anaesthetic agents (Shearer, 1960) . However, increasing controversy over their effectiveness as premedicants has raised questions about the justification for their continued routine use before operation (Kessell, 1974; Leigh ton and Sanders, 1976; Mirakhur, Dundee and Connolly, 1979) particularly since the drugs can cause unpleasant side-effects, including restlessness, dizziness and blurring of vision, tachycardia, pain at the injection site and dryness of the mouth.
Since hyoscine has been reported to produce amnesia, there have been some studies of its effects in volunteers. These have reported significant effects of the drug on the ability to store new information (Safer and Allen, 1971; Drachman and Leavitt, 1974; Ghoneim and Mewaldt, 1975) , but no effect on the ability to recall information which had been presented before its administration (Petersen, 1977) . A few clinical studies have used simple tests of memory, such as asking patients whether they remembered the journey to the operating theatre (Pandit and Dundee, 1970) , but these revealed only gross memory impairments. The effects of atropine on memory have not been investigated and only one study (Hardy and Wakely, 1962) has compared the effects of atropine and hyoscine. Few studies have attempted to look at the duration of any effect. Furthermore, comparisons between studies are difficult because of the different drug dosages and routes of administration used, as well as the variety of memory tests.
Any potential advantages gained by the use of atropine and hyoscine as premedicants must be weighed against their physiological as well as their cognitive side-effects. A comparison of the latter is important so that clinicians can be aware of their differential effects on memory and motor skills. As these drugs are used commonly as premedication in day case surgery, an investigation of the comparative duration of any cognitive side-effects may be useful in helping clinicians decide whether a patient is fit for discharge, especially when it is known that patients do not always heed the advice given about driving home. There is a clear lack of a comparative study of the nature and duration of the cognitive effects of atropine and hyoscine as they are used in clinical practice, and this study was designed to fill such a gap.
PATIENTS AND METHODS
Thirty patients (age range 22-55 yr) undergoing dilatation and curettage of the uterus were studied after giving informed consent. The patients performed a battery of psychological tests 30 min before premedication. They were then allocated randomly to one of three experimental groups: hyoscine 0.4 mg i.m., atropine 0.6 mg i.m. or placebo (physiological saline 1 ml) i.m. Testing was repeated 30 min after premedication. One hour after premedication, anaesthesia was induced with thiopentone 500 mg and maintained with 70% nitrous oxide and halo thane in oxygen. The battery of tests was repeated 1 and 3 h after return to the ward. At all times, the test administrator and the patient were unaware of the identity of the premedicant drug.
Every patient performed the psychological tests in the following order: (1) Vocabulary (from the Wechsler Adult Intelligence Scale). This gave an estimate of IQ and was administered on the first testing occasion only. Patients were tested using the Leeds Psychomotor Tester. In this task 6 LED were arranged in a semi-circle on a board with a button adjacent to each. Patients placed an index finger on a central button and when one of the LED lit up, they had to press the button adjacent to it as quickly as possible, thus extinguishing the light. The test box automatically recorded response latencies (time to lift finger off the central button) and total reaction times (time to extinguish the light). Fifteen CRT were collected on each testing occasion, and patients were allowed practice trials on the first occasion only. (8) Memory Test. Four lists, of 12 words each, were compiled for the four testing occasions. The words were read out at the rate of one per second and patients were asked to recall each list immediately following presentation (immediate recall) and again at the following testing occasion (delayed recall). The words were equated for familiarity according to Thorndike and Lorge (1944) . (9) Cancellation Task. Patients were instructed to cross out, as quickly as possible, all letters P in six rows of 25 random typed capital letters, on the first testing occasion and three other versions requiring them to cross out the letters R, A and B were compiled for the further testing occasions (time and errors scored).
(10) Gibson Spiral Maze Test (Gibson, 1978) . Patients were instructed to draw a continuous line through the maze as quickly as possible without touching the edges or the circles within it (time and errors scored).
RESULTS
There were no significant differences between the ages of the patients in the three experimental groups. Patients were tested at the times set out in the method; however, carrying out this study in the setting of a busy hospital ward where the time that patients went into the operating theatre varied from day to day, meant that the intervals between test times were not constant. These intervals were compared, and found to be not significantly different between the three groups.
One-way analyses of variance were carried out to compare the three treatment groups on each test score for the four different testing occasions (trials 1, 2, 3 and 4). In addition, difference scores between trials 1 and 2,2 and 3,3 and 4, and 1 and 4 were computed for each test and further one-way analyses of variance carried out to compare the treatment groups, this being a more powerful analysis of the results.
In all, 159 of these analyses were performed and there were 25 significant results (P < 0.05). Eight such results would be expected by chance. This, as well as consistency among those test scores producing significant results, makes it unlikely that all of these results were attributable to chance. Table I details the tests and the trials on which the treatment groups were found to perform significantly diffe-rently, and also shows which of the three groups performed significantly differently from each other (Tukey's Honestly Significant Difference test (Tukey, 1949) ). Tl  T2  T3  T4  T3  T4  T4  T4-T1  T4  T4-T1  T3  T4  T3-T2  T4-T1   T3   T3  T4  T4- 
Test results
The patients allocated to the three treatment groups did not differ significantly from each other on the Vocabulary test. The treatment groups did not differ significantly on any comparison on the automatized series, on the alphabet task, or on the forwards digit span task. On the backwards digit span test, patients given hyoscine and patients given atropine performed significantly worse than the placebo group in trial 2 (after drug administration) (P < 0.05). In trial 3, the hyoscine group continued to perform significantly less well than the placebo group (P < 0.01), but all differences between the groups had disappeared by trial 4 (3 h after return from the operating theatre).
On all of the rest of the tests, the significant differences were either between the hyoscine group and the placebo group or between the hyoscine group and both the placebo and the atropine groups, while there were no significant differences at any time between the atropine and the placebo groups.
Mood scales. Patients given hyoscine rated themselves as being significantly less bored than patients given the placebo, in trial 3,1 h after return from the operating theatre, compared with trial 2, 30 min after drug administration (P < 0.05), and in trial 4 (3 h after return from the operating theatre) compared with trial 3 (P < 0.05). They also rated themselves as being significantly less anxious than patients in the placebo group in trial 3 compared with trial 2 (P < 0.05).
Orientation. Patients given hyoscine scored significantly fewer points on the orientation questions than both the placebo and the atropine groups, in trial 4, and in trial 4 compared with trial 1 (P < 0.01 in both cases). This was the result of their inability to answer one question correctly ("What is the time?") while patients in the other two groups were always able to estimate the time correctly to the nearest halfhour.
Memory tests.
Patients who received hyoscine recalled significantly fewer words than patients given atropine and those given the placebo in trials 2 (P < 0.01), 3 (P < 0.001) and 4 (P < 0.05). However, they had recalled significantly fewer words than the placebo group only, in trial 1 (before drug administration) (P < 0.05). The comparisons of the difference scores between trials were not significant, despite an increase in the levels of significance of the effects found between the hyoscine and the other two groups in trials 2 and 3, which indicated that patients-who had received hyoscine recalled fewer words immediately compared with patients who had received atropine and those who had received the placebo, 30 min after drug administration and 1 h after return from the operating theatre, but not in trial 4, 3 h after their return.
The treatment groups did not differ on the delayed recall of List 1, which had been presented before drug administration. In the later trials, when hyoscine had affected immediate recall, analyses of delayed recall were carried out, not on the actual number of words recalled on the delayed test, but as a percentage of the number which had been recalled immediately. In trial 3, patients given hyoscine recalled significantly fewer words after the interval between trials 2 and 3 than the placebo group (P < 0.01), and in trial 4, they also recalled significantly fewer words after the interval between trials 3 and 4 than the atropine group (P < 0.01). Thus, the ability to recall the words again after an interval was impaired for the lists which were presented after drug administration, but not for the list which had been presented before drug administration. This impairment of delayed recall was evident up to the last trial, 3 h after return from the operating theatre.
Choice reaction time. To reduce the effect of chance inattention, any CRT exceeding the mean + two standard deviations were excluded from the analyses. In trial 4, patients who had received hyoscine had significantly slower total CRT than patients in both the placebo and atropine groups (P < 0.01) and slower latency CRT than the placebo group (P < 0.01). However, when comparing trial 4 with trial 1, both total and latency CRT were significantly slower for patients receiving hyoscine than both the placebo and atropine groups (P < 0.05 and P < 0.01, respectively). In other words, the difference in performance between the last and the first testing occasions for patients who had received hyoscine was greater than for patients in the other two groups; they were slower both to initiate motor movement and to complete it.
Cancellation test. In trial 3 (1 h after return from the operating theatre) patients given hyoscine were significantly slower to complete this test than those in the atropine and placebo groups (P < 0.01), and made significantly greater numbers of errors-that is, missing targets (P < 0.01). Comparing trial 3 with trial 2, the hyoscine group were significantly slower than the atropine group (P < 0.05). In the last trial, patients who had received hyoscine were still significantly slower than patients in the placebo group (P < 0.05) and comparing trial 4 with trial 1, they were significantly slower than patients in both the atropine and the placebo groups (P < 0.01). They also made a total of 12 false positive errors in trial 4, while patients in the atropine group made a total of 5, and patients in the placebo group made a total of only 2.
Gibson maze test. In trial 3, patients who had been given hyoscine performed significantly more slowly than patients given the placebo (P < 0.05). In trial 4, and comparing trial 4 with trial 1, they also performed significantly more slowly than patients who had received atropine (P < 0.05). There were no significant differences between the groups in the number of errors made on any of the comparisons.
DISCUSSION
This study has shown significant differences in the performance of patients between those who had received hyoscine and those who had received atropine or the placebo on certain tests. Moreover, some of the differences were evident still on the last testing occasion-which took place 1-2 h before day -case patients were due for discharge. On the other hand, patients who received atropine and those who received the placebo differed in their performance of only one test 30 min after drug administration (backwards digit span). Wetherell (1980) had found an effect of atropine on volunteers' performance of a forwards digit span test, 1 h after a large dose (2 mg) of atropine i.m., but not on backwards digit span.
Only two out of the six self-rated mood scales, those measuring interest and anxiety, showed that patients given hyoscine were less bored and less anxious than patients who received the placebo. These effects were probably the result of the greater sedative action of hyoscine (Longo, 1966; Shutt and Bowes, 1979) . Some authors have suggested that the sedative action of hyoscine is a desirable effect, as it reduces anxiety before the operation (Pandit, Dundee and Keilty, 1971) . However, in the present study, the differences on the mood scales were not shown until after the operation. Only one orientation question ("What time is it?") was answered correctly less often by patients who had received hyoscine, again probably as a result of the fact that they were more drowsy after the operation than the other patients and, therefore, less able to notice a clock or to ask the time.
Hyoscine had no effect on the ability to perform simple tasks such as reciting the alphabet or repeating short series of digits. This is in agreement with other studies (Safer and Allen, 1971; Drachman and Leavitt, 1974; Ghoneim and Mewaldt, 1975) , in which hyoscine was administered by different routes and in different doses, and in which digit span was tested 1 h after administration. None of these studies tested backwards digit span performance, which was shown to be affected by hyoscine in the present study, suggesting that hyoscine affects the more complex ability to both store and operate on information at the same time. This effect, however, was not evident on the last trial (3 h following operation).
Hyoscine had some effect on the ability to recall meaningful information immediately, which was clearest 30 min after administration, and 1 h after return from the operating theatre. The ability to recall information which had been presented before drug administration, after an interval of about 1 h, was not significantly affected by hyoscine, a finding in agreement with those of Ghoneim and Mewaldt (1975) and Petersen (1977) . However, the present study did reveal an impairment, in comparison with atropine and the placebo, of recall after intervals of several hours when the information had been presented while patients were under the influence of the drug, and this effect was apparent even on the last testing occasion. Petersen (1977) found such an effect only with a large (10 \ig kg i.v.) injection of hyoscine. This study showed, therefore, that hysocine affected information acquisition but, more importantly, it affected retrieval processes when information was presented after the administration of the drug, and this may have implications for anaesthetists giving instructions or other information to patients.
The greatest effect of hyoscine was to slow down motor speed and visuo-motor co-ordination, effects which were apparent for many hours after return from the operating theatre. Some patients given hyoscine complained of blurred vision during the cancellation test 1 h after return from the operating theatre, which may partly account for the greater number of targets which they missed, but none complained of this on the last testing occasion, when the most false positive errors were made. Thus, patients who receive hysocine as a premedication in day-case surgery may still be affected by it at the time of their discharge from hospital.
This study has revealed information about the nature of the cognitive effects of hyoscine, as used in clinical practice, while it has shown that the clinical dose of atropine has minimal effects on cognitive performance compared with a placebo. It raises the question of whether the dose of hysocine used most often in clinical practice (0.4 mg) could be reduced without decreasing its effectiveness as a premedicant. Mirakhur, Dundee and Connolly (1979) , however, recommended that the most effective dose of hyoscine i.m., in terms of its antisialagogue action, is 0.5 mg. This study has also shown that the effects of hyoscine on motor functions may last up to the time of discharge from hospital in day-case surgery, which suggests that patients should be informed of the side-effects of hyoscine and that perhaps such information would increase compliance with advice about journeying home.
